Abstract: Panniculitis is a rare clinical finding in dermatomyositis, with less than 30 cases reported and there is only one case associated with the amyopathic subtype described in the literature. The present report describes a 49-year-old female patient that one year after being diagnosed with amyopathic dermatomyositis, presented indurated, painful, erythematous to violaceous nodules located on the upper limbs, thighs and gluteal region. Skin biopsy revealed lobular panniculitis with a lymphocytic infiltrate. The patient was treated with prednisone and methotrexate, but remained unresponsive to treatment.
INTRODUCTION
Dermatomyositis is an autoimmune, chronic, idiopathic, inflammatory disease that affects the striated skeletal muscles, the skin and other organs. 1 Clinical features of the disease vary greatly and have been classified into five groups: amyopathic dermatomyositis, juvenile dermatomyositis, primary dermatomyositis, dermatomyositis associated with neoplasms and dermatomyositis associated with other connective tissue disorders. 1 Amyopathic dermatomyositis constitutes 2-18% of patients with dermatomyositis and is characterized by pathognomonic cutaneous lesions of dermatomyositis, histopathology compatible with the disease and no evidence of muscle disease. 2, 3 Panniculitis is a rare skin manifestation of dermatomyositis and less than 30 cases of such association have been published since 1924, of which only one reported such association with the amyopathic subtype. 4 We present a case of a 49-year-old patient that one year after being diagnosed with amyopathic dermatomyositis showed a clinical condition compatible with lobular panniculitis.
CASE REPORT
We attended a 49-year-old female patient with erythematous papules on metacarpophalangeal joints and violaceous erythema on the face, cervical region, upper back and upper limbs ( The clinical manifestations of panniculitis may precede other symptoms of dermatomyositis, appear simultaneously with the disease or during the first five years of the disease. 8 In cases where skin lesions occur coupled with muscle disease, panniculitis and dermatomyositis follow a parallel clinical course, with both conditions improving simultaneously during treatment. Thus, muscle disease should be investigated if the subcutaneous inflammation deteriorates. 9 However, in this case report, muscle enzyme levels and electroneuromyography showed normal results during the course of two years of the disease. The presence of panniculitis in a patient with dermatomyositis may be indicative of a good prognosis as it responds better to treatment and is rarely associated with underlying neoplasms. Of the 25 cases published, only in five solid neoplasms were detected in patients with dermatomyositis manifesting panniculitis. 8 In the present case, screening for malignancy was negative.
The treatment of choice consists of corticosteroids, which in most cases results in a fast and complete recovery. Methotrexate and intravenous immunoglobulin may be used in patients who fail to respond to corticosteroids 4, 8 Chao et al. reported a case of a patient with dermatomyositis and panniculitis in which the lesions improved after treatment with methotrexate, however, the patient still felt ill and intravenous immunoglobulin was necessary. 10 Even though treating panniculitis with corticosteroids will usually result in a good clinical response, our patient's condition did not improve and multiple, painful subcutaneous nodules were still observed after treatment with prednisone (1mg/kg/day) and methotrexate.
Although the association of dermatomyositis and panniculitis is rare, one must consider dermatomyositis in patients with lobular panniculitis, even if there is no evidence of muscle disease. In fact, such association may be indicative of a good prognosis. q
